Key facts
- It has raised $5.5M; the latest was Seed Round ($5.5M) in Sep 2025.
- Notable investors include KB Investment, Korea Investment Partners, UTC Investment, Company K Partners, Laplace Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for CoBX BIO
- ·The full record, as it builds
Funding rounds
No funding rounds for CoBX BIO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CoBX BIO
Operator of a drug development company intended to remove disease proteins. The company is currently operating in stealth mode.
- Sector
- Business Products and Services (B2B)
- HQ
- Gyeonggi, South Korea
- Founded
- 2024
- Ownership
- Privately Held (backing)
CoBX BIO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoBX BIO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoBX BIO in its N-PORT filings yet. We sweep new filings monthly.